Israel

The race for the generics business of Germany's Merck KGaA looks to be heading into the final stages with two firms thought to be leading the bidding - Israel's Teva , and US-based... 2007-05-11

Israeli firm Teva 's second innovative drug offering Azilect (rasagiline tablets), which treats Parkinson's disease, has continued its successful market entry helping the company... 2007-05-09

Israel is the most advanced pharmaceuticals sector in the Middle East, boasting one of the highest per capita spending in the region. The market, despite the limited population numbers,... 2007-05-03

Israel's intellectual property laws are harming investment in the country, claims the Office of the US Trade Representative (USTR) in its newly released National Trade Estimate Report.... 2007-04-11

Israel is the most advanced pharmaceuticals sector in the Middle East, boasting one of the highest per capita spends in the region. The market, despite the limited population numbers,... 2007-03-01

Israeli drugmaker Teva Pharmaceutical Industries is seriously considering pulling out of a US$100mn biotechnology investment in Hungary because of the country's new drug subsidy framework.... 2007-02-28

Israeli drugmaker Teva has announced record results for 2006, with sales rising by 60% to reach US$8.4bn. This dynamic performance was driven by the integration of IVAX - which... 2007-02-13

Israeli generics firm

Israel's chemicals and pharmaceuticals sector is forecast to post a 15% rise in exports in 2007, bringing the total value of the sector up to US$10bn, according to the Manufacturer's... 2007-01-29

German drugmaker